Popular terms

Respiratory topics
Respiratory
Ventilation
Respiratory Distress Syndrome
Executable
Computer Readable
Expiration
Respiration
Sleep Apnea
Medical Device
Continuous Positive Airway Pressure
Ventilator
Acute Respiratory Distress Syndrome
Antagonist
Cardiovascular Health
Cardiovascular

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Respiratory patents



      

This page is updated frequently with new Respiratory-related patent applications.




Date/App# patent app List of recent Respiratory-related patents
06/16/16
20160169889 
 Diagnosis of respiratory tract infectious disease using urine specimens patent thumbnailDiagnosis of respiratory tract infectious disease using urine specimens
Provided are a method for detecting respiratory infection associated with bacterial infection, a method for selecting patients with respiratory infection to receive an antibiotic, and a method for determining the timing for ending administration of an antibiotic to a patient with respiratory infection receiving the antibiotic, wherein said methods are characterized in that they are able to appropriately select patients with respiratory infection to whom the antibiotic is to be administered, to adjust the administration period of the antibiotic, and to treat respiratory infection associated with bacterial infection, and in that a measured value of scd14-st in urine is used as an indication.. .
Mochida Pharmaceutical Co., Ltd.


06/16/16
20160168207 
 Respiratory syncytial virus (rsv) vaccine patent thumbnailRespiratory syncytial virus (rsv) vaccine
The present invention relates to an mrna sequence, comprising a coding region, encoding at least one antigenic peptide or protein of rsv infections respiratory syncytial virus (rsv) or a fragment, variant or derivative thereof. Additionally the present invention relates to a composition comprising a plurality of mrna sequences comprising a coding region, encoding at least one antigenic peptide or protein of rsv infections respiratory syncytial virus (rsv) or a fragment, variant or derivative thereof.
Curevac Ag


06/16/16
20160168124 
 Substituted pyridine-piperazinyl analogues as rsv antiviral compounds patent thumbnailSubstituted pyridine-piperazinyl analogues as rsv antiviral compounds
The invention concerns novel substituted pyridine-piperazinyl analogues of formula (i) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (rsv). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection..
Janssen Sciences Ireland Uc


06/16/16
20160166970 
 Filtering material and use thereof patent thumbnailFiltering material and use thereof
The present invention relates to an adsorptive filter unit (i.e. A filter structure or filter media, respectively), which is especially intended for the purification of gases and/or gas mixtures, preferably air, and/or for the removal of chemical and/or biological substances or noxiants from gases and/or gas mixtures, preferably air, in particular for use in or as a respiratory filter or gas-mask filter..
Blücher Gmbh


06/16/16
20160166798 
 Mouthpiece for controlled delivery of a breathing gas patent thumbnailMouthpiece for controlled delivery of a breathing gas
The present invention relates to a mouthpiece for controlled delivery of a breathing gas including oxygen, preferably an increased ratio of oxygen with respect to ambient air, to the respiratory tracts of a user comprising a valve having two modes; a closed default mode, which substantially impedes any flow of the breathing gas through the valve; and an active open mode, which allows for a substantial flow of the breathing gas through the valve, wherein the open mode can be activated by the user manipulating the valve with his/her mouth. The invention also relates to the use of such a valve in a device for delivery of breathing gas and further to an apparatus for controlled delivery of the breathing gas to the respiratory tracts of a user.
Resmed R&d Germany Gmbh


06/16/16
20160166795 
 Device, system and  positive pressure ventilation (ppv) resuscitation to continuous positive airway pressure (cpap) patent thumbnailDevice, system and positive pressure ventilation (ppv) resuscitation to continuous positive airway pressure (cpap)
The resuscitation method and device incorporates a t-piece and/or bag and mask resuscitation device that transforms into short term (and then long term) cpap device. This results in continuum of respiratory care in the delivery room, and potentially in the nursery.
General Electric Company


06/16/16
20160166790 
 Ultrasonic measurements for monitoring patients using respiratory therapy delivery devices patent thumbnailUltrasonic measurements for monitoring patients using respiratory therapy delivery devices
Systems and methods for delivering therapy and/or medicament to a subject use one or more sensors to generate signals that represent characteristics of ultrasonic energy emitted during the use of respiratory medicament delivery devices. Parameters based on these signals indicate energy amplitude in one or more frequency ranges.
Koninklijke Philips N.v.


06/16/16
20160166787 
 Monitoring respiratory parameters through ultrasonic measurements indicating flow changes in respiratory drug delivery devices patent thumbnailMonitoring respiratory parameters through ultrasonic measurements indicating flow changes in respiratory drug delivery devices
Systems and methods for delivering medicament to a subject use one or more sensors to generate signals that represent characteristics of the ultrasonic energy emitted into or by a respiratory medicament delivery device. Parameters based on these signals indicate energy amplitude in one or more frequency ranges.
Koninklijke Philips N.v.


06/16/16
20160166621 
 Non-chemotherapeutic antibiotic treatment for infections in cattle patent thumbnailNon-chemotherapeutic antibiotic treatment for infections in cattle
Compositions and methods for treating and/or preventing bacterial infections in animals such as bovines are provided. The compositions and methods utilize the predatory bacterium bdellovibrio bacteriovorus to treat and/or prevent infections such as infectious bovine keratoconjunctivitis (ibk) and bovine respiratory disease (brd).
The Board Of Regents Of The University Of Oklahoma


06/16/16
20160166520 
 Methods and compositions relating to the treatment of visceral fat and asthma patent thumbnailMethods and compositions relating to the treatment of visceral fat and asthma
The technology described herein is directed to methods of treating, e.g., obesity and/or asthma which relate to the interacting roles of chi3l1 and sirt1 in controlling adipose tissue and respiratory health.. .
Yale University


06/16/16
20160166505 

Methods and compositions for treatment of respiratory tract infections


A method of treating a patient for an upper or lower respiratory tract infection includes mixing a dry powder pharmaceutical composition including tobramycin with a base liquid to produce a nebulizer solution dosage form. The method may further include encapsulating the powder in a capsule and dispensing the capsule for the subsequent mixing of the powder with the base prior to administration to the patient via intranasal nebulization..
Cmpd Licensing, Llc


06/16/16
20160166176 

Computer-based analysis of oscillatory ventilation


This document provides systems and techniques that can be used to provide computer-implemented interpretation (e.g., up-to-date, on demand, and real time interpretation) of respiratory profiles of patients using, for example, an application provided by a computer server system, to assess a patient's cardiac and/or pulmonary function.. .
Mayo Foundation For Medical Education And Research


06/16/16
20160166175 

Determining respiratory gas exchange in a subject


The present disclosure provides examples of a method, including: providing a representative inhale-exhale cycle breathing volume over time profile; and when the subject performs at least one inhale-exhale cycle that meets a correspondence criterion related to the representative profile, using data relating to oxygen consumption or carbon dioxide production during the inhale-exhale cycle that met the correspondence criterion to determine a metabolic property in the subject.. .
Meta Flow Ltd.


06/16/16
20160165972 

Sleep apnea prevention mask


A sleep apnea prevention sleep-aid mask is described. The sleep-aid mask is configured to secure the lips of a user together in a natural state, in order to encourage the respiratory system of the user to employ the nasal passages rather than the mouth for respiration.

06/16/16
20160165960 

Expandable three in one swaddler


A swaddler which is suitable for a child from birth until when the baby rolls over. It has two interior pockets and a removable seam to extend its length, allowing for a better sized fit during baby growth stages.
Brownmed, Inc.


06/09/16
20160165387 

Smart home platform with data analytics for monitoring and related methods


A smart home system with data analytics for home monitoring or for monitoring enclosed spaces other than the home. The system can include a ble mesh network with an embedded gateway and a plurality of repeater nodes running ble mesh software for use with a cloud server for receiving data from the gateway through wifi communication.

06/09/16
20160161506 

Diagnosis of respiratory tract infectious disease using blood specimens


Provided are a method for detecting respiratory infection associated with bacterial infection, a method for selecting patients with respiratory infection to receive an antibiotic, and a method for determining the timing for ending administration of an antibiotic to a patient with respiratory infection receiving the antibiotic, wherein said methods are characterized in that they are able to appropriately select patients with respiratory infection to whom the antibiotic is to be administered, to adjust the administration period of the antibiotic, and to treat respiratory infection associated with bacterial infection, and in which a measured value of scd14-st in blood is used as an indication.. .
Mochida Pharmaceutical Co., Ltd.


06/09/16
20160161505 

Diagnosis and risk stratification using nt-proet-1


The invention relates to a method for the diagnosis and/or risk stratification of cardiac diseases and diseases of the respiratory tract and lungs. According to said method, the free fragment n-terminal proendothelin (nt-proet-1; amino acids 18-52 of the preproet according to fig.
Brahms Gmbh


06/09/16
20160159886 

Stabilized liquid anti-rsv antibody formulations


The present invention provides liquid formulations of synagis® or an antigen-binding fragment thereof that immunospecifically bind to a respiratory syncytial virus (rsv) antigen, which formulation exhibit stability, low to undetectable levels of aggregation, and very little to no loss of the biological activities of synagis® or an antigen-binding fragment thereof, even during long periods of storage. In particular, the present invention provides liquid formulations of synagis® or an antigen-binding fragment thereof which immunospecifically binds to a rsv antigen, which formulation are substantially free of surfactant, inorganic salts, and/or other common excipients furthermore, the invention provides method of preventing, treating or ameliorating symptoms associated with rsv infection utilizing liquid formulations of the present invention..
Medimmune, Llc


06/09/16
20160159870 

Compositions and methods of use for recombinant human secretoglobins


Methods of synthetically producing, formulating and using secretoglobins scgb1a1, scgb3a2, and scgb3a1 are provided. Methods of using secretoglobins scgb1a1, scgb3a2, and scgb3a1 as therapeutic agents to affect long term patient outcomes, such as preventing severe respiratory exacerbations of underlying conditions that require medical intervention, including hospitalization are provided.
Therabron Therapeutics, Inc.


06/09/16
20160159794 

Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection


Wherein r1, r2, r3, r4, r5, w and x are as described herein, compositions including the compounds and methods of using the compounds.. .

06/09/16
20160159793 

Fused pyrroledicarboxamides and their use as pharmaceuticals


The present invention relates in fused pyrroledicarboxamides of the formula (i), in which r1 to r9, x, m and n are as defined in claims. The compounds of the formula (i) are inhibitors of the acid-sensitive potassium channel task-1 and suitable for the treatment of task-1 channel-mediated diseases such as arrhythmias, in particular atrial arrhythmias like atrial fibrillation or atrial flutter, and respiratory disorders, in particular sleep-related respiratory disorders like sleep apnea, for example..
Sanofi


06/09/16
20160158482 

Apparatus for humidifying a respiratory gas


The invention concerns an apparatus for supplying a respiratory gas, a humidifying apparatus, a respiratory gas tube and a connecting apparatus therefor. The apparatus of the invention includes a blowing device for delivering the respiratory gas, a housing device which has a bottom region, a top surface region and a side region extending upwardly between the top surface region and the cover region, as well as a connecting device for connecting a humidifying apparatus for humidifying the respiratory gas, wherein the connecting device is arranged in the side region of the apparatus in such a way that the humidifying apparatus can be laterally coupled thereto.
Resmed R&d Germany Gmbh


06/09/16
20160158478 

Modularized respiratory treatment apparatus


A modularized respiratory treatment apparatus provides various respiratory pressure treatments. The apparatus may be formed by discrete connectable modules such as a flow generator module, alarm module and/or humidifier module.
Resmed Limited


06/09/16
20160158369 

Pharmaceutical composition for respiratory administration


The present invention provides a pharmaceutical composition for respiratory administration containing a polysaccharide derivative having a group derived from a polysaccharide and a group derived from a physiologically active substance that is covalently bonded to the group derived from a polysaccharide.. .
Seikagaku Corporation


06/09/16
20160158363 

Multi-tailed lipids and uses thereof


The present invention provides multi-tailed lipid compounds, and salts and stereoisomers thereof, and methods of preparing the compounds. Also provided are compositions including a compound of the invention and an agent (e.g., an sirna, mrna, plasmid dna, small molecule, protein, peptide).
Massachusetts Institute Of Technology


06/09/16
20160158336 

Attenuated mannheimia haemolytica vaccines and methods of making and use


The present invention provides attenuated m. Haemolytica strains that elicit an immune response in animals against m.

06/09/16
20160158282 

Tungstate treatment of the dysbiosis associated with gastrointestinal inflammation


The present invention provides compositions of therapeutic agents and methods of use for reducing and/or treating gastrointestinal inflammation. In particular aspects, the tungstate salts described herein and pharmaceutical compositions thereof inhibit the activity of one or a plurality of anaerobic respiratory enzymes in facultative anaerobic bacteria such as, for example, enterobacteriaceae, that can exacerbate inflammation.
The Regents Of The University Of California


06/09/16
20160158179 

Nanoemulsion therapeutic compositions and methods of using the same


The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus burkholderia) in a subject administered the immunogenic composition.
The Regents Of The University Of Michigan


06/09/16
20160158093 

Device for optimization of sleep apnea syndrome therapy by kinesthetic stimulation


The disclosure relates to a device including a processor configured to detect a respiratory disorder episode and generate kinesthetic stimulation control signals in response to the detection of a respiratory disorder episode. The device further includes at least one kinesthetic effector adapted to be applied to a patient's outer skin site and includes a vibrating electromechanical transducer capable of receiving stimulation control signals and outputting a kinesthetic stimulation energy determined by the stimulation control signals.
UniversitÉ De Rennes 1


06/09/16
20160158092 

System for respiratory disorder therapy with stabilization control of stimulation


The disclosure relates to a system including a processor configured to generate stimulation control signals in response to a detection of a respiratory disorder. The system further includes at least one kinesthetic effector with a vibrating electromechanical transducer applied to a site on a patient's skin for delivering a kinesthetic stimulation energy determined by the control signals.
Inserm- Institut De La Recherche MÉdicale


06/09/16
20160158091 

System for respiratory disorder therapy with selection of stimulation strategies


The disclosure relates to a system including a processor configured to generate stimulation control signals in response to a detection of a respiratory disorder. The system further includes at least one kinesthetic effector with a vibrating electromechanical transducer applied to a site on a patient's skin for delivering a kinesthetic stimulation energy determined by the control signals.
UniversitÉ De Rennes 1


06/02/16
20160151649 

Respiratory protection equipment


respiratory protection hood comprising a flexible envelope and a reservoir of pressurized oxygen comprising an outlet orifice that leads into the internal volume of the envelope, the outlet orifice being closed off by a removable stopper, characterized in that the reservoir of oxygen comprises, upstream of the orifice, a passage for the pressurized gas and a needle that is able to move in a given direction of displacement in said passage, the needle being subjected to two opposite forces in the direction of displacement, said forces being respectively generated on the one hand by the pressure of the gas in the reservoir and the other hand by a return member, the needle having a section with a defined profile that is variable in the direction of displacement in order to modify the degree of closure of the passage depending on the position of said needle relative to the passage so as to regulate the flow rate of gas allowed to escape via the passage towards the orifice as a function of time and the pressure of gas in the reservoir.. .
L'air Liquide, Societe Anonyme Pour L'etude Et I'exploitation Des Procedes Georges Claude


06/02/16
20160151599 

Humidification system


The present invention provides a method for reducing condensed humidifying agent in a humidification system by pulsing a delivery of humidifying agent into a respiratory circuit. During a non-pulsed interval, gas flowing through the respiratory circuit will evaporate the condensed humidifying agent present in the respiratory circuit.
Carefusion 2200, Inc.


06/02/16
20160151590 

Determining of subject zero flow using cluster analysis


Systems and method for determining zero subject flow rate for correcting leak estimation in respiratory devices. Estimating leak in respiratory devices is necessary for proper ventilation of the subject.
Koninklijke Philips N.v.


06/02/16
20160151393 

Pulmonary pharmaceutical formulations


The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (hsh).
Civitas Therapeutics, Inc.


06/02/16
20160151014 

Methods and heart failure treatment


Methods and apparatus for assessing the condition of and treating patients for heart failure by the delivery of continuous positive airway pressure are disclosed. Treatment of obstruction due to reflex vocal cord closure often experienced by heart failure patients is distinguished from treatment of upper airway obstruction typically associated with obstructive sleep disorder.
Resmed Limited


06/02/16
20160150998 

Methods and devices for determining pulmonary measurement


A method for determining at least one instantaneous pulmonary measurement. The method comprises providing a plurality of instantaneous mechanical pulmonary properties of a user in at least one identified respiratory instant during at least one respiration cycle, correlating between the plurality of instantaneous mechanical pulmonary properties, and determining at least one instantaneous pulmonary measurement in at least one identified respiratory instant according to the correlation during the at least one respiration cycle..
Pulmone Advanced Medical Devices, Ltd.


06/02/16
20160150982 

Wearable respiratory inductance plethysmography device and respiratory activity analysis


It is described a system and a method for respiratory activity analysis comprising the use of respiratory inductance plethysmography (rip). In particular, a wearable system for extracting physiological parameters of a person by measuring at least one plethysmographic signal is disclosed.
Carre Technologies Inc.


06/02/16
20160150981 

Monitoring systems


We describe a medical device, in embodiments a battlefield triage device, configured to be attached to and carried by a person. The device comprises a sensor module to attach to a person's face.
Cambridge Design Partnership Llp


06/02/16
20160150966 

Automatic continuous patient movement monitoring


A monitoring system (10) includes at least one video camera (14), a motion unit (40), and a segmentation unit (42). The at least one video camera (14) is configured to continuously receive video of a subject in normal and darkened room conditions.
Koninklijke Philips N.v.


05/26/16
20160148539 

Dry powder inhaler respiratory training device and system


Embodiments of a respiratory inhaler training device to provide stepwise instructions for using the device to a user in a sequence of steps are provided herein. The respiratory inhaler training device may include a housing defining a channel with an inlet and an outlet, at least one actuation mechanism simulating provision of medicament, at least one fluid flow rate sensor positioned so as to detect fluid flow in the channel, a signal output component for providing an output to the user, a microprocessor comprising a timekeeping component, a storage medium component associated with the microprocessor comprising a database of instructions pertaining to the sequence and/or timing of steps for using the device stored thereon, one or more program code modules stored on the microprocessor or the storage medium component, or a combination thereof, wherein the one or more program code modules include a first program code module for causing the microprocessor to provide a first instruction, and a second program code module for causing the microprocessor to provide a subsequent instruction based on a current register..

05/26/16
20160146848 

Subject monitor


An embodiment includes an apparatus with a housing wearable by a subject and a first sensor operable to detect a position of the subject. An embodiment of the apparatus includes a second sensor operable to detect a body state of the subject, where the first body state may be a vital sign such as heart rate, blood pressure, body temperature or respiratory rate.
Stmicroelectronics (beijing) R&d Co. Ltd


05/26/16
20160144147 

Arrangement and the in-vitro and in-vivo treatment of bronchial tumors


The aim of the invention to provide an arrangement and a method for operating said arrangement for the in-vitro and in-vivo treatment of bronchial tumors, with said arrangement making the lungs receptive to ultrasound in order to allow the mechanical ultrasound waves to be guided through the healthy lung tissue to the tumor tissue in an optimized manner for the use of fus therapy, is achieved in that the arrangement comprises a ventilation and respirator system (1) for a lung part to be provided with a gas for respiratory purposes (33), a device for the controlled ventilation and flooding (2) of a lung part to be flooded (34) with a liquid, a therapy system (4), and a central control unit (5), wherein the therapy system (4) consists of at least one therapeutic ultrasonic transducer (40), an imaging-monitoring system (42), and a temperature-monitoring system (41), and the central control unit (5) is connected to the therapeutic ultrasonic transducer (40), the respirator system (1), the device for the controlled ventilation and flooding processes (2), the imaging-monitoring system (42), and the temperature-monitoring system (41) for data-transmission purposes, the respirator system (1) and the device for the controlled ventilation and flooding (2) processes have a gas- and liquid-conducting connection to a lung tube (3), the lung tube (3) can be inserted into a lung containing a tumor (35) in an intratracheal manner, and therapeutic ultrasound doses can be administered by the ultrasonic transducer (40).. .

05/26/16
20160144144 

A patient interface system for treatment of respiratory disorders


A patient interface system to treat a respiratory disorder of a patient, the patient interface system comprising: a positioning and stabilising structure including a back portion and a pair of upper straps extending from the back portion; and a patient interface including a patient interface frame and a pair of rigidiser arms each connected to the patient interface frame at a connection point located in a plane substantially parallel to the patient's frankfort horizontal plane, the pair of rigidiser arms further including a pair of upper attachment points, wherein the pair of upper straps are adapted to be releasably attached to the pair of upper attachment points such that, when donned by the patient, the pair of upper straps are vertically offset relative to the connection points and substantially parallel to the patient's frankfort horizontal plane, and wherein the patient interface does not include a forehead support.. .
Resmed Limited


05/26/16
20160144142 

Metered dose respiratory training device and system


In an embodiment, a respiratory inhaler training device configured to provide stepwise instructions for using the device to a user in a sequence of steps is provided. The respiratory inhaler training device includes a housing defining a channel with an inlet and an outlet, at least one actuation mechanism simulating provision of medicament, at least one fluid flow rate sensor positioned so as to detect a rate of fluid flow through the channel to determine a fluid flow rate, a signal output component for providing an output, a microprocessor and a timekeeping component, a storage medium component associated with the microprocessor comprising a database of instructions pertaining to the sequence and/or timing of steps for using the device stored thereon..

05/26/16
20160143915 

New cyclohexylamine derivatives having ß2 adrenergic agonist and m3 muscarinic antagonist activities


The present invention relates to novel compounds having β2 adrenergic agonist and m3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.. .
Almirall, S.a.


05/26/16
20160143880 

Use of glycopyrrolate for treating tachycardia


The invention relates to a novel use of the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the invention relates to glycopyrrolate for use as a heart rate lowering agent and more particularly, but not exclusively, for use in patients suffering from respiratory conditions such as chronic obstructive pulmonary disease..
Sosei R&d Ltd.


05/26/16
20160143729 

Regenerative respiratory tract prostheses


A regenerative respiratory tract prosthesis comprising a tubular extracellular matrix (ecm) member having a lumen therethrough, at least first and second biodegradable polymeric anchors disposed on the tubular member exterior surface. The first and second anchors can include a microneedle tissue engagement member..
Cormatrix Cardiovascular, Inc.


05/26/16
20160143575 

Swallowing estimation device, information terminal device, and storage medium


A swallowing estimation device includes: a sound detection part configured to detect sound of a larynx portion; a respiration detection part configured to detect respiration; and a swallowing estimation part configured to estimate swallowing based on sound information outputted from the sound detection part and based on respiration information outputted from the respiration detection part. The swallowing estimation part obtains a value of a parameter for swallowing estimation with respect to a biological sound generation interval that corresponds to a respiratory cessation interval longer than or equal to 400 msec, and estimates whether swallowing has occurred in the biological sound generation interval based on whether the obtained value of the parameter satisfies a swallowing determination condition..
Eusense Medical Co., Ltd.


05/26/16
20160143547 

Rapid rate-estimation for cell phones, smart watches, occupancy, and wearables


Techniques for respiratory and metabolic monitoring in mobile devices, wearable computing, security, illumination, photography, and other applications may use a phosphor-coated broadband white led to produce broadband light, which may be transmitted along with ambient light to a target (e.g., ear, face, wrist, or the like). Some scattered light returning from a target may be passed through a spectral filter to produce multiple detector regions sensitive to a different waveband and/or wavelength range, and the detected light may be analyzed to determine a measure of a respiratory rate or effort.
Aliphcom


05/26/16
20160143546 

System for calibrating a blood pressure measurement based on vascular transit of a pulse wave


The invention provides a system and method for measuring vital signs (e.g. Sys, dia, spo2, heart rate, and respiratory rate) and motion (e.g.
Sotera Wireless, Inc.


05/19/16
20160140867 

Fatigue indices and uses thereof


Example embodiments may relate to a system, method, apparatus, and computer readable media configured for monitoring a user performing an athletic movement and/or exercise and generating a fatigue value. Fatigue values may be determined for different groups.
Nike, Inc.


05/19/16
20160137699 

Recombinant fusion antigen gene, recombinant fusion antigen protein and subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus


The present invention is directed to a recombinant fusion antigen gene, a recombinant fusion antigen protein and a subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus (prrsv). A recombinant fusion antigen gene, which encodes glycoprotein gp5 with truncated n′-terminal decoy epitope, a linker sequence and membrane protein m, followed by codon optimization, is expressed by a baculovirus expression system in vitro, thereby enhancing a yield of the recombinant fusion antigen protein.
National Pingtung University Of Science And Technology


05/19/16
20160136378 

Filtration unit useable in a respiratory therapy device


A filtration module for comprises a filter housing defining two or more filter compartments. The housing has an input side with a gas inlet in fluid communication with each of the filter compartments and a gas outlet in fluid communication with each of the filter compartments.
Hill-rom Services Pte Ltd.


05/19/16
20160136371 

System and circuits to allow cpap to provide zero pressure


A system comprises a respiratory delivery arrangement adapted to cover at least one respiratory orifice of a patient. The system also comprises a first conduit having a first end and a second end, the second end connected to the respiratory delivery arrangement.
New York University


05/19/16
20160136367 

Respiratory therapy apparatus and methods


A vibratory pep respiratory therapy device (100) includes a valve element (11) on a rocker arm (12) that opens and closes an opening (10) during exhalation through the apparatus. An accelerometer (20) including a piezoelectric beam (22) supported at one end (23) is mounted on the outside of the housing (2) of the device to respond to vibration transmitted though the housing caused by oscillating movement of the rocker arm (12).
Smiths Medical International Limited


05/19/16
20160136366 

Respiratory therapy apparatus and methods


respiratory therapy apparatus includes device (100) with a rocker arm (12) supporting a valve (11) that opens and closes an expiration opening (10) so that an oscillating resistance to flow is produced accompanied by an alternating sound at the frequency of oscillation. The apparatus also includes a sensor (20) with a microphone (21) that detects sound from the device (100) transmitted through air.
Smiths Medical International Limited


05/19/16
20160136119 

Dp2 antagonist and uses thereof


Described herein is the dp2 antagonist [2′-(3-benzyl-1-ethyl-ureidomethyl)-6-methoxy-4′-trifluoromethyl-biphenyl-3-yl]-acetic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the dp2 antagonist, or a pharmaceutically acceptable salt thereof.
Brickell Biotech, Inc.


05/19/16
20160135756 

Clinical metric for predicting onset of cardiorespiratory deterioration in patients


A system generates and displays a clinical metric based on continuously collected patient physiological data, wherein the clinical metric provides a predictive measure of the likelihood of the onset of a cardiorespiratory deterioration event in the patient in a predetermined time period in the future. If the clinical metric has a configured relationship with a predetermined threshold value, embodiments may generate an alarm in addition to or instead of displaying the clinical metric.

05/19/16
20160135734 

Combination therapy for sleep disordered breathing and heart failure


Methods and apparatus provide evaluation of a cardiac condition of a patient with sleep disordered breathing. One or more processors, such as processors associated with any of icds, crts and/or respiratory pressure therapy devices, may be configured to receive data representing one or more respiratory parameters for the patient.
Resmed Limited


05/19/16
20160135715 

Method for respiratory measurement


The invention is directed method for measuring respiration using impedance pneumography over a duration of at least several minutes, several hours or over the duration of night sleep, the method comprising: using at least one electrode (11) configured to be in contact with an arm (2) of a human body (1) and at least one electrode (22) configured to be in skin contact with the thorax of a human body (1); defining impedance signal changes which relate to the respiratory volume changes or time-differentiated impedance signal changes which relate to the respiratory flow; and analysing variation over time in flow-time, volume-time, flow-volume curves, or derived numerical indices, or plain respiratory impedance signal or its time derivate over the duration of at least several minutes, several hours or over the duration of night sleep.. .
Tide Medical Oy


05/12/16
20160130275 

Pyrazolo[1,5-a]pyrimidines for antiviral treatment


Or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating pneumovirinae virus infections.

05/12/16
20160130245 

6,8-substituted naringenin derivative and use thereof


In which a6 and a8 in formula (i) are respectively selected from h, halogen, hydroxyl, an alkyl group with 1-3 carbon atoms, and a straight-chain alkenyl, alcohol group, aldehyde group, or carboxylic acid group containing 2-3 carbon atoms, obtained by modifying naringenin as lead compound, or a pharmaceutically acceptable salt thereof, a preparation method therefor and use thereof in preparation of drugs for improving the function of the respiratory system and relieving cough.. .



Respiratory topics: Respiratory, Ventilation, Respiratory Distress Syndrome, Executable, Computer Readable, Expiration, Respiration, Sleep Apnea, Medical Device, Continuous Positive Airway Pressure, Ventilator, Acute Respiratory Distress Syndrome, Antagonist, Cardiovascular Health, Cardiovascular

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Respiratory for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Respiratory with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.722

5376

2 - 1 - 104